Intellia Therapeutics (NTLA) Net Margin Growth (3y) (2018 - 2026)
Intellia Therapeutics (NTLA) Net Margin Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,283.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 6,537.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Intellia Therapeutics | 1.32 Bn | 1.32 Bn | - | -1,288.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,288.00 |
| Dec 31, 2025 | 39,886.00 |
| Sep 30, 2025 | 4,901.00 |
| Jun 30, 2025 | 62,069.00 |
| Mar 31, 2025 | 156,465.00 |
| Dec 31, 2024 | -34,433.00 |
| Sep 30, 2024 | 777,057.00 |
| Jun 30, 2024 | 1.39 Mn |
| Mar 31, 2024 | 668,318.00 |
| Dec 31, 2023 | 1.13 Mn |
| Sep 30, 2023 | -101,175.00 |
| Jun 30, 2023 | -88,476.00 |
| Mar 31, 2023 | -97,814.00 |
| Dec 31, 2022 | -52,576.00 |
| Sep 30, 2022 | -122,633.00 |
| Jun 30, 2022 | -108,495.00 |
| Mar 31, 2022 | -270,905.00 |
| Dec 31, 2021 | -39,587.00 |
| Sep 30, 2021 | -826,824.00 |
| Jun 30, 2021 | -1.48 Mn |